Cambridge Journal of Science and Policy
About this collection
Recent Submissions
-
The Future of Miniaturised Organs in Drug Development and Testing
Drug development is time consuming and expensive, partly due to the difficulty ofdetermining the safety and effectiveness of drugs in humans. To improve this process,there is a demand for models appropriate for studying ... -
The Role of Patients and Patient Activism in the Development of Long COVID Policy
The COVID-19 pandemic has focused on the acute respiratory phase of SARS-CoV-2 infection which has killed over three million people globally [1]. Attention is now increasing on the serious long-term, multi-organ illness ... -
Dementia Implementation Plan Review: its role in dementia policy and future perspectives
This work reviews dementia policy in the UK using the Prime Minister’s Dementia Challenge 2020 Implementation Plan and the Phase 1 Review of the plan provided by the Department of Health and Social Care (DHSC). The proposed ... -
Why it’s time to stop considering Evidence-Based Policy and Evidence-Based Medicine as analogous when it comes to Randomized Controlled Trials: An argument from Clinical Equipoise
Randomized Controlled Trials (RCTs) play a large role in both Evidence-Based Medicine (EBM) and Evidence-Based Policy (EBP). However, in this paper, I question whether the role of RCTs is directly analogous in the two ...
